Source: Science News

Parkinson's disease is a long-term neurological condition in which the brain cells responsible for producing dopamine gradually deteriorate. Dopamine is a neurotransmitter that plays a key role in coordinating movement. As a result, people living with Parkinson's commonly experience tremors, muscle rigidity, slowed movement, and problems with balance or coordination. The debilitating disorder affects an estimated 1 million to 1.5 million people in the United States, and currently, there is no known cure.

But there may be a glimmer of hope. A new noninvasive ultrasound procedure is showing promise in relieving tremors, stiffness, and chronic pain without the need for traditional brain surgery. The treatment, known as high-intensity focused ultrasound, uses MRI imaging to help doctors precisely target malfunctioning brain circuits with more than 1,000 sound waves while patients remain awake during the procedure. The revolutionary technique does not require incisions, anesthesia, or permanent hardware.

According to researchers, the approach may serve as an alternative for patients who are either ineligible for invasive surgery or prefer a less intensive option. Unlike deep brain stimulation, the procedure also does not require implanted electrodes or ongoing maintenance.

The therapy was first approved by the U.S. Food and Drug Administration in 2018. Since then, advances in neurological science have helped refine the technology, leading to the approval of a newer version in 2025 that expands treatment to additional brain targets. The updated approach may help address not only tremors, but also slowness, rigidity, involuntary movements, and muscle-related pain. Doctors are now also able to perform the procedure on both sides of the brain, potentially extending symptom relief throughout the body.

Recently, a clinical trial involving 40 participants produced encouraging results. Patients who underwent bilateral ultrasound treatment reported roughly a one-third improvement in movement-related disability when off medication. About 86% of participants also said their overall Parkinson's symptoms improved within three months of treatment.

Although focused ultrasound therapy is currently available mainly at major academic medical centers, interest in the procedure continues to grow among people living with Parkinson's disease. Researchers caution that the treatment is not a cure and does not stop disease progression, and long-term results are still being studied. Still, many experts remain optimistic because of the immediate symptom relief some patients experience after treatment, including reduced tremors, improved mobility, less pain, and better sleep.

For now, many people living with Parkinson's can only hope that continued advances in focused ultrasound technology will further improve treatment outcomes and ultimately enhance quality of life for those affected by the disease.